Fulgent Genetics Inc.

NASDAQ: FLGT · Real-Time Price · USD
21.89
0.15 (0.69%)
At close: Aug 15, 2025, 10:02 AM

Fulgent Genetics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-43.82M -167.82M 141.92M 506.24M
Depreciation & Amortization
24.93M 26.14M 32.66M 11M
Stock-Based Compensation
44.48M 42.92M 32.64M 15.88M
Other Working Capital
6M 7.35M -41.29M -32.77M
Other Non-Cash Items
-793K 115.31M 43.46M 15.97M
Deferred Income Tax
-3.74M 7.61M 831K -7.84M
Change in Working Capital
n/a 2.84M 2M -2.68M
Operating Cash Flow
21.06M 27M 253.52M 538.58M
Capital Expenditures
-40.31M -22.21M -18.77M -23.84M
Cash Acquisitions
n/a -399K -182.68M -61.87M
Purchase of Investments
-472.42M -491.91M -432.98M -730.49M
Sales Maturities Of Investments
454.06M 552.64M 372.71M 269.59M
Other Investing Acitivies
313K 775K 412K 63K
Investing Cash Flow
-58.35M 38.9M -261.31M -546.55M
Debt Repayment
-1.77M -5M -1.07M -11K
Common Stock Repurchased
-3.12M -27.79M -76.11M -4.16M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
51K -17.73M 31K 96K
Financial Cash Flow
-4.85M -47.78M -77.14M 85.39M
Net Cash Flow
-42.19M 17.97M -85.39M 77.47M
Free Cash Flow
-19.25M 4.8M 234.75M 514.73M